Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/EVOKE PHARMA INC/ 10-K/A

SEC Filing · 10-K/A

EVOKE PHARMA INC

SEC Filing

Filed May 14, 2024Accepted May 14, 2024, 12:05 PM EDTCIK 1403708Accession 0000950170-24-059516
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
EVOKOTC · EQUITY · Historical · closed Dec 16, 2025

Recent company filings

  1. 15-12G filingDec 30, 2025
  2. SCHEDULE 13D/A - filed by Nantahala Capital Management, LLC regarding Evoke Pharma IncDec 19, 2025
  3. EFFECT filingDec 18, 2025
  4. EFFECT filingDec 18, 2025
  5. EFFECT filingDec 18, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗